Study of Dexycu in Treating Intraocular Inflammation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a phase III, prospective, randomised, double-masked, placebo-controlled, parallel-design, multicenter study of the efficacy, safety and pharmacokinetics of 9% dexamethasone intraocular injection for the treatment of inflammation associated with cataract surgery.
Epistemonikos ID: 144a9e58f27fbfbc779182f4ae332b9e635621a3
First added on: Jun 01, 2024